| From: | Becker’s ASC Review <editorial@beckershealthcare.com> |
| Subject: | [Key specialties edition] Outpatient vs. inpatient orthopedic procedures: Where are the cost-savings? | Valeant Pharmaceuticals’ Salix to pay $54M for alleged illegal kickbacks: 6 things to know | Pain management device market to hit $4.64B by 2021: 5 things to know | Zimmer Biomet to acquire LDR in $1B transaction – 9 things to know |
| Preheader: | |
| Reply: | editorial@beckershealthcare.com |
|